U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07334886) titled 'A Study of [14C]Ulonivirine ([14C]MK-8507) in Healthy Adults (MK-8507-006)' on Dec. 31, 2025.

Brief Summary: The goal of this study is to learn how [14C]ulonivirine moves through a healthy person's body over time. Researchers will study how [14C]ulonivirine is absorbed by the body, broken down by the body, and how it leaves the body.

Study Start Date: Sept. 17, 2025

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: [14C]Ulonivirine

Oral Solution

Recruitment Status: COMPLETED

Sponsor: Merck Sharp & Dohme LLC

Disclaimer: Curated by HT Syndication....